Subscribe


PD breaking news – Actavis to exit Australian generics

Allergan Australia and New Zealand acquisition completed. 

Actavis has confirmed it will exit the Australian generics business, as part of the completed acquisition of Allergan Australia and New Zealand.

This included the generic hospital, generic pharmaceutical, Pierre Fabre and Medico businesses.

“In the interim, Actavis will continue to supply the Australian market with high quality generic medicines through its current distribution channels while alternative distribution models are actively explored.”

The Actavis New Zealand generic market would continue with no change.

Actavis would also seek shareholder approval to change its name to Allergan in May or June, although the Actavis name could continue to be used for certain regions and products, Allergan said.

Allergan ANZ vice president and md Glen Curran said it was “very much business as usual” and in the short term, the company was working to integrate the companies smoothly.

“During this process we are committed to keeping all of our customers informed of our progress.”

The combined company would offer an expanded portfolio of innovator products, Allergan said.

Curran said about $1.7b would be invested globally in R&D this year.

For more, see tomorrow’s Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 25 Mar 15

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

19 Jan

Dispensary Corner 19 Jan 18 - IT MAKES perfect sense for the operation ...


19 Jan

PBA data released - THE Pharmacy Board of Australia has released ...


19 Jan

‘Out of pocket pain’ - THE Consumers Health Forum (CHF) has announced ...


19 Jan

Cannabis PBS listing? - VICTORIAN Health Minister Jill Hennessy has confirmed ...


19 Jan

Industrial hemp meet - THE Australian Industrial Hemp Conference is calling ...


19 Jan

S3 advertising permitted - THE Therapeutic Goods Administration has confirmed that ...


19 Jan

Codeine story ‘misleading’ - WHILE the rescheduling of products containing codeine ...


18 Jan

Travel Specials 18 Jan 18 - VIEW & Verandah Sale by Holland America ...


18 Jan

Dispensary Corner 18 Jan 18 - NEWLYWEDS from Northern Ireland have wasted no ...


18 Jan

CW float speculation - THE owners of Chemist Warehouse may be ...


18 Jan

Life-Long Learning - THE Australian Pharmacy Council has announced the ...


18 Jan

FIP Glasgow regos - REGISTRATIONS have opened for the 78th International ...


18 Jan

Vic Guild election - THE Victorian Branch of the Pharmacy Guild ...


18 Jan

Blood clot warning - A DRUG that women use as a ...


18 Jan

TGA reformats PIs - EFFECTIVE 01 Jan this year, all product ...


18 Jan

PBA competency standards - THE Pharmacy Practitioner Development Committee (PPDC) met ...


18 Jan

The eyes have it - RESEARCH conducted by the University of Queensland ...


18 Jan

Pharmacy role in National Pain Plan - PHARMACISTS have been identified as key advisors ...


18 Jan

SHPA affirms codeine move - THE Society of Hospital Pharmacists of Australia ...


17 Jan

Ibuprofen Double Strength 400 - ARROW Pharmaceuticals announces the launch of Chemists' ...



Show Pharmacy Daily items by month: